University College London Hospitals NHS Trust
London, NW1 2PG, United Kingdom
NCT Number: NCT05838196
Study to determine whether the use of an ultrasound completed during an inflammatory bowel disease (IBD) clinic will speed up diagnosis, treatment initiation, reduce complications, save money and reduce investigations compared with our current standard of care.
Looking for future studies?
Notify Me16 year and older
All sexes
Interventional
Not applicable
London, NW1 2PG, United Kingdom
After being provided with study information and providing written informed consent, participants attending the inflammatory bowel disease clinic will be randomised to standard of care or to receiving an ultrasound during the clinic appointment. This ultrasound result will be used to determine treatment decisions. Participants will have a 6 month follow-up to capture outcome data and further medical record review will be conducted at one year.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Point-of-care ultrasound performed during clinic appointment
Time frame: 6 months
Time in days for when a new medication is started, dose changed, medication stopped, or surgery performed following the clinic appointment
Time frame: Immediate
Does the clinical decision made before ultrasound differ from that following ultrasound.
Time frame: 6 months
Using formalised imaging or endoscopy as gold standard for determining disease activity, compare findings on POCUS to determine sensitivity and specificity
Time frame: 1 year
Using NHS cost tariffs, estimated costs for participants following standard of care to those receiving POCUS over the year following enrolment
Time frame: 6 months
POCUS will be performed by gastroenterologists or radiologist and outcomes on sensitivity/specificity will be compared between the two
Time frame: 6 months
Using disease activity score questionnaires (HBI (If Crohn's disease) or SCCAI (If ulcerative Colitis)) at baseline and six months.
Time frame: 1 year
Number of courses of steroids and total steroid dose over the duration of the trial
Time frame: 6 months
Are there significant difference between the change in haemaglobin from baseline to six months in the POCUS group compared with standard of care
Time frame: 6 months
Are there significant difference between the change in CRP from baseline to six months in the POCUS group compared with standard of care
Time frame: 6 months
Are there significant difference between the change in platelets from baseline to six months in the POCUS group compared with standard of care
University College, London
Other
Does the Use of Point of Care Ultrasound During Inflammatory Bowel Disease Clinic Appointments Change Management, Speed up Treatment Decisions and Save Money: a Feasibility and Service Development Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04757181
Digestive System Diseases, Gastroenteritis
Worcester, Massachusetts, United States
View Trial DetailsNCT03938324
Anemia, Anemia, Hemolytic
Durham, North Carolina, United States
View Trial DetailsNCT06094608
Colitis, Colitis, Ulcerative
Ann Arbor, Michigan, United States
View Trial DetailsNCT05809999
Colonic Diseases, Colonic Neoplasms
Edmonton, Alberta, Canada
View Trial Details